Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034)
The launch of emerging therapies like BESREMi (PharmaEssentia and AOP Orphan Pharmaceuticals), INCB057643 (Incyte), XPOVIO (Karyopharm Therapeutics), RYTELO…